Platelet Concentration Articles & Analysis
2 news found
Cellphire Therapeutics, Inc., a biotechnology company developing next-generation platelet-based hemostatic therapeutics for application across multiple medical indications, announced today that the first patient has been dosed in the company’s Phase 2 dose-ranging study of Thrombosomes®, a platelet-based freeze-dried hemostatic agent, in bleeding ...
The hemostat’s action is due to the synergistic effect of 5 product features and mechanisms, four of which are protected by this patent, that collect, aggregate and concentrate platelets to produce fast hemostasis and stable clot formation. ...